Drug Abuse Methodology: Training and Interdisciplinary Application

药物滥用方法:培训和跨学科应用

基本信息

  • 批准号:
    8242430
  • 负责人:
  • 金额:
    $ 17.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This K01 application responds to PA-10-056, and is intended to obtain support and "protected time" for Dr. Rajeev I. Desai (PI) to gain extensive supervised research training and experience in all aspects of intravenous (IV) self-administration methodology in non-human primates (NHP). The project is designed to systematically allow the PI to acquire necessary skills and experience to independently and expertly study the reinforcing effects of stimulant and other addictive drugs, and to couple this methodology with concurrent in vivo microdialysis to measure related neurochemical activity. The support provided by the K01 award will ultimately allow the PI to: a) develop a comprehensive program of highly translational neurochemical and behavioral studies to directly address the public health concern of stimulant addiction and the development of medications for its treatment; and b) acquire the tools necessary to independently continue and expand this line of research through R01 funding mechanisms. The aims of this project are designed to optimize the PI's training experience through a systematic series of experiments evaluating IV cocaine and nicotine self- administration behavior under simple and complex schedules of reinforcement. The PI next will couple his existing expertise with in vivo microdialysis techniques to his newly acquired behavioral skills to measure changes in striatal dopamine levels produced by cocaine and nicotine during IV self-administration performance under different schedule conditions. Finally, studies will be conducted to determine whether nicotinic agonist-based candidate medications attenuate reinforcing and neurochemical effects of self- administered nicotine or cocaine. The proposed research in this project will establish the PI as a well-trained and independent young scientist who is qualified to conduct highly translational addiction research in NHP. In addition, the planned studies may lead to the further development of promising novel nicotinic-based pharmacotherapy to help combat the scourge of stimulant addiction that plagues our public health. PUBLIC HEALTH RELEVANCE: Translational behavioral and neurochemical methodologies are an integral part of drug addiction research methodology, and there is a clear need for trained scientists who are qualified to conduct this type of multi- dimensional work in nonhuman primates. This project is designed to systematically provide a young investigator with intensive supervised research training to directly measure the reinforcing effects of addictive drugs and their associated neurochemical changes in highly translational procedures. The proposed research will lead to a greater understanding of neurochemical mechanisms in psychomotor stimulant addiction, and may identify novel nicotinic targets to help combat this public health concern.
描述(由申请人提供):此K01申请响应PA-10-056,旨在为Rajeev I.Desai(PI)博士获得支持和“保护时间”,以便在非人类灵长类动物(NHP)静脉注射(IV)自我给药方法学的所有方面获得广泛的监督研究培训和经验。该项目旨在系统地让PI获得必要的技能和经验,以独立和专业地研究兴奋剂和其他成瘾药物的增强作用,并将该方法与体内同步微透析相结合,以测量相关的神经化学活动。K01奖项提供的支持最终将使PI能够:a)开发一个高度翻译的神经化学和行为研究的综合计划,以直接解决兴奋剂成瘾引起的公共健康问题,并开发治疗兴奋剂成瘾的药物;以及b)获得必要的工具,通过R01资助机制独立地继续和扩大这一研究领域。本项目的目的是通过一系列系统的实验来评估在简单和复杂的强化计划下静脉注射可卡因和尼古丁的自我给药行为,以优化PI的训练体验。接下来,PI将把他现有的专业知识与体内微透析技术结合起来 他新获得的行为技能,以测量在不同时间表条件下静脉注射自我给药期间,可卡因和尼古丁产生的纹状体多巴胺水平的变化。最后,将进行研究,以确定尼古丁激动剂为基础的候选药物是否减弱自我给药尼古丁或可卡因的强化和神经化学效应。该项目中拟议的研究将使PI成为一名训练有素、独立的年轻科学家,有资格在NHP进行高度翻译性成瘾研究。此外,计划中的研究可能会导致有希望的基于尼古丁的新型药物疗法的进一步发展,以帮助对抗困扰我们公共健康的兴奋剂成瘾的祸害。 公共卫生相关性:翻译行为和神经化学方法是药物成瘾研究方法中不可或缺的一部分,显然需要训练有素的科学家,他们有资格在非人类灵长类动物身上进行这类多维工作。该项目旨在系统地为年轻的研究人员提供高强度的监督研究培训,以直接衡量成瘾药物的强化效果及其相关的神经化学变化在高度翻译的程序中。这项拟议的研究将有助于更好地理解精神运动性兴奋剂成瘾的神经化学机制,并可能确定新的尼古丁靶点,以帮助解决这一公共卫生问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rajeev Indrajit Desai其他文献

Rajeev Indrajit Desai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rajeev Indrajit Desai', 18)}}的其他基金

Drug Abuse Methodology: Training and Interdisciplinary Application
药物滥用方法:培训和跨学科应用
  • 批准号:
    8607173
  • 财政年份:
    2012
  • 资助金额:
    $ 17.23万
  • 项目类别:
Drug Abuse Methodology: Training and Interdisciplinary Application
药物滥用方法:培训和跨学科应用
  • 批准号:
    8434813
  • 财政年份:
    2012
  • 资助金额:
    $ 17.23万
  • 项目类别:
Nicotinic Modulation of Methamphetamine's Behavioral and Neurochemical Effects
烟碱对甲基苯丙胺的行为和神经化学作用的调节
  • 批准号:
    7739907
  • 财政年份:
    2009
  • 资助金额:
    $ 17.23万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
  • 批准号:
    10534864
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了